MetLife Investment Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $12.5M | Sell |
22,252
-729
| -3% | -$467K | 0.06% | 300 |
|
|
2025
Q4 | $15.5M | Sell |
22,981
-705
| -3% | -$480K | 0.08% | 238 |
|
|
2025
Q3 | $15.1M | Sell |
23,686
-486
| -2% | -$295K | 0.07% | 248 |
|
|
2025
Q2 | $13M | Sell |
24,172
-624
| -3% | -$298K | 0.08% | 244 |
|
|
2025
Q1 | $10.4M | Sell |
24,796
-449
| -2% | -$195K | 0.06% | 317 |
|
|
2024
Q4 | $10.4M | Buy |
25,245
+85
| +0.3% | +$37.3K | 0.06% | 252 |
|
|
2024
Q3 | $12.7M | Sell |
25,160
-690
| -3% | -$335K | 0.07% | 201 |
|
|
2024
Q2 | $12.6M | Buy |
25,850
+3,013
| +13% | +$1.51M | 0.07% | 193 |
|
|
2024
Q1 | $12.3M | Sell |
22,837
-714
| -3% | -$390K | 0.08% | 183 |
|
|
2023
Q4 | $13.1M | Sell |
23,551
-399
| -2% | -$187K | 0.09% | 168 |
|
|
2023
Q3 | $10.5M | Sell |
23,950
-536
| -2% | -$267K | 0.08% | 192 |
|
|
2023
Q2 | $12.3M | Sell |
24,486
-153
| -0.6% | -$73.3K | 0.09% | 170 |
|
|
2023
Q1 | $12.3M | Sell |
24,639
-249
| -1% | -$119K | 0.09% | 174 |
|
|
2022
Q4 | $10.2M | Sell |
24,888
-673
| -3% | -$261K | 0.08% | 207 |
|
|
2022
Q3 | $8.33M | Sell |
25,561
-471
| -2% | -$173K | 0.07% | 232 |
|
|
2022
Q2 | $9.13M | Sell |
26,032
-822
| -3% | -$335K | 0.07% | 218 |
|
|
2022
Q1 | $14.7M | Buy |
26,854
+8,119
| +43% | +$4.27M | 0.1% | 165 |
|
|
2021
Q4 | $12.3M | Sell |
18,735
-481
| -3% | -$302K | 0.1% | 158 |
|
|
2021
Q3 | $12M | Sell |
19,216
-556
| -3% | -$374K | 0.11% | 152 |
|
|
2021
Q2 | $12.5M | Sell |
19,772
-585
| -3% | -$323K | 0.11% | 155 |
|
|
2021
Q1 | $9.96M | Sell |
20,357
-359
| -2% | -$180K | 0.09% | 177 |
|
|
2020
Q4 | $10.4M | Sell |
20,716
-850
| -4% | -$380K | 0.1% | 167 |
|
|
2020
Q3 | $8.48M | Sell |
21,566
-648
| -3% | -$240K | 0.09% | 181 |
|
|
2020
Q2 | $7.33M | Buy |
22,214
+102
| +0.5% | +$29.5K | 0.08% | 200 |
|
|
2020
Q1 | $5.36M | Sell |
22,112
-676
| -3% | -$176K | 0.07% | 232 |
|
|
2019
Q4 | $5.95M | Sell |
22,788
-640
| -3% | -$169K | 0.06% | 284 |
|
|
2019
Q3 | $6.37M | Sell |
23,428
-279
| -1% | -$77.6K | 0.07% | 255 |
|
|
2019
Q2 | $6.53M | Sell |
23,707
-741
| -3% | -$183K | 0.07% | 258 |
|
|
2019
Q1 | $5.47M | Sell |
24,448
-213
| -0.9% | -$44K | 0.06% | 306 |
|
|
2018
Q4 | $4.59M | Sell |
24,661
-528
| -2% | -$108K | 0.06% | 318 |
|
|
2018
Q3 | $6.29M | Sell |
25,189
-382
| -1% | -$92.7K | 0.06% | 277 |
|
|
2018
Q2 | $5.57M | Sell |
25,571
-648
| -2% | -$134K | 0.07% | 270 |
|
|
2018
Q1 | $5.02M | Sell |
26,219
-767
| -3% | -$142K | 0.06% | 317 |
|
|
2017
Q4 | $4.22M | Buy |
+26,986
| New | +$4.25M | 0.05% | 427 |
|
Other funds holding IDXX
VCM
VPM
MetLife Investment Management's IDXX Position: Q1 2026 in Review
MetLife Investment Management reduced its Idexx Laboratories (IDXX) stake by 3.2% in Q1 2026, selling an estimated $467K and leaving 22,252 shares worth $12.5M. The position accounts for 0.06% of the portfolio, ranked #300.
MetLife Investment Management first reported a position in IDXX in Q4 2017 and has held it in 34 quarters since. The position peaked at $15.5M in Q4 2025. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.
- MetLife Investment Management held 22,252 shares of Idexx Laboratories worth $12.5M as of Q1 2026.
- MetLife Investment Management sold 729 Idexx Laboratories shares in Q1 2026, an estimated $467K.
- Idexx Laboratories made up 0.06% of MetLife Investment Management's portfolio in Q1 2026, its #300 holding.
- MetLife Investment Management first reported a position in Idexx Laboratories in Q4 2017 and has held it in 34 quarters since.
- MetLife Investment Management's Idexx Laboratories position peaked at $15.5M in Q4 2025.
- 1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.
Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.